Wall Street Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Wall Street Financial Group's PFE Position: Q2 2026 in Review
Wall Street Financial Group increased its Pfizer (PFE) stake by 1.7% in Q2 2026, buying an estimated $3.87K and bringing the position to 8,795 shares worth $212K. The position accounts for 0.11% of the portfolio, ranked #116.
Wall Street Financial Group first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $243K in Q1 2026. 1,189 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Wall Street Financial Group held 8,795 shares of Pfizer worth $212K as of Q2 2026.
- Wall Street Financial Group bought 148 Pfizer shares in Q2 2026, an estimated $3.87K.
- Pfizer made up 0.11% of Wall Street Financial Group's portfolio in Q2 2026, its #116 holding.
- Wall Street Financial Group first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
- Wall Street Financial Group's Pfizer position peaked at $243K in Q1 2026.
- 1,189 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.